These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8293411)

  • 1. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
    Wu LT; Averbuch SD; Ball DW; de Bustros A; Baylin SB; McGuire WP
    Cancer; 1994 Jan; 73(2):432-6. PubMed ID: 8293411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
    Deutschbein T; Matuszczyk A; Moeller LC; Unger N; Yuece A; Lahner H; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):540-3. PubMed ID: 21667440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide.
    Lupoli G; Cascone E; Arlotta F; Vitale G; Celentano L; Salvatore M; Lombardi G
    Cancer; 1996 Sep; 78(5):1114-8. PubMed ID: 8780551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer.
    Orlandi F; Caraci P; Berruti A; Puligheddu B; Pivano G; Dogliotti L; Angeli A
    Ann Oncol; 1994 Oct; 5(8):763-5. PubMed ID: 7826911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
    Hajje G; Borget I; Leboulleux S; Chougnet C; Al Ghuzlan A; Mirghani H; Caramella C; Hartl D; Schlumberger M; Baudin E
    Eur J Endocrinol; 2013 Feb; 168(2):113-8. PubMed ID: 23093698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
    Stein R; Chen S; Reed L; Richel H; Goldenberg DM
    Cancer; 2002 Jan; 94(1):51-61. PubMed ID: 11815960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.
    Stein R; Goldenberg DM
    Mol Cancer Ther; 2004 Dec; 3(12):1559-64. PubMed ID: 15634649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
    Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
    Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine.
    Averbuch SD; Steakley CS; Young RC; Gelmann EP; Goldstein DS; Stull R; Keiser HR
    Ann Intern Med; 1988 Aug; 109(4):267-73. PubMed ID: 3395037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature.
    Deutschbein T; Fassnacht M; Weismann D; Reincke M; Mann K; Petersenn S
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):84-90. PubMed ID: 25143180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil.
    Petursson SR
    Cancer; 1988 Nov; 62(9):1899-903. PubMed ID: 3167804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma.
    Juweid ME; Hajjar G; Swayne LC; Sharkey RM; Suleiman S; Herskovic T; Pereira M; Rubin AD; Goldenberg DM
    Cancer; 1999 Apr; 85(8):1828-42. PubMed ID: 10223579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.
    Huang H; Abraham J; Hung E; Averbuch S; Merino M; Steinberg SM; Pacak K; Fojo T
    Cancer; 2008 Oct; 113(8):2020-8. PubMed ID: 18780317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
    Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination therapy with adriamycin, cisplatin and vindesine in C cell carcinoma of the thyroid].
    Scherübl H; Raue F; Ziegler R
    Onkologie; 1990 Jun; 13(3):198-202. PubMed ID: 2204006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
    Schlumberger M; Abdelmoumene N; Delisle MJ; Couette JE
    Br J Cancer; 1995 Feb; 71(2):363-5. PubMed ID: 7530987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
    Quayle FJ; Moley JF
    J Surg Oncol; 2005 Mar; 89(3):122-9. PubMed ID: 15719378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin analogs in the treatment of medullary thyroid carcinoma.
    Díez JJ; Iglesias P
    J Endocrinol Invest; 2002 Oct; 25(9):773-8. PubMed ID: 12398235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine and dacarbazine in a combined chemotherapy.
    Noshiro T; Honma H; Shimizu K; Kusakari T; Watanabe T; Akama H; Shibukawa S; Miura W; Abe K; Miura Y
    Endocr J; 1996 Jun; 43(3):279-84. PubMed ID: 8886621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.